BioNTech SE

NASDAQ: BNTX · Real-Time Price · USD
113.54
0.84 (0.75%)
At close: Aug 15, 2025, 3:59 PM
113.81
0.24%
After-hours: Aug 15, 2025, 07:27 PM EDT

BioNTech SE Cash Flow Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-677.7M 1.19B 12.95B 15.05B
Depreciation & Amortization
311.38M 183.4M 123.3M 75.2M
Stock-Based Compensation
100.9M 51.4M 108.6M 93.9M
Other Working Capital
n/a n/a -50.87M n/a
Other Non-Cash Items
-734.1M -1.62B -4.13B 212.5M
Deferred Income Tax
-10.55M n/a n/a -3.79B
Change in Working Capital
1.22B 5.57B 4.52B -10.73B
Operating Cash Flow
207.7M 5.37B 13.58B 889.7M
Capital Expenditures
-452.3M -705.5M -363.3M -154M
Cash Acquisitions
1.25M -336.9M 589.19K -20.8M
Purchase of Investments
-12.37B -6.98B -47.8M -410.44M
Sales Maturities Of Investments
10.74B 1.19B 375.2M 26.5M
Other Investing Acitivies
-164.6M -576.59M 10.81K -23.1M
Investing Cash Flow
-2.08B -6.95B -35.3M -566.1M
Debt Repayment
-2.4M -40.1M -59.1M -66.7M
Common Stock Repurchased
n/a -738.5M -986.4M n/a
Dividend Paid
n/a n/a -475.58M n/a
Other Financial Acitivies
-43.5M n/a 110.5M -14.66M
Financial Cash Flow
-45.9M -778.6M -1.42B 94.2M
Net Cash Flow
-1.9B -2.21B 12.18B 482.5M
Free Cash Flow
-244.6M 4.67B 13.21B 735.7M